glp 1 on medicaid Pennsylvania stopped covering GLP-1s for obesity this year, but it's not all savings How the Medicare GLP-1 Bridge

Some long-time followers simply say rizk when summarizing brand familiarity within a broader market conversation

[DOI] [PMC free article] [PubMed] [Google Scholar] 754.Orskov C., Poulsen S.S., Moller M., Holst J.J

Some people are not candidates, including pregnancy and breastfeeding scenarios, which is why Safety considerations / medical supervision matters

Novo Nordisk Headquarters: Bagsvrd, Denmark Number of employees: 77,000 Year founded: 1923 Revenue (2025): $42.1 billion Forbes overall rank: 42 In 2025, Novo Nordisk reported full-year sales of about DKK 309.1 billion (roughly $45 billion), a ~6% increase in Danish kroner and ~10% at constant exchange rates, driven mainly by obesity and diabetes semaglutide products Wegovy and Ozempic, though operating profit growth was modest and weighed down by transformation costs and pricing pressures